Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Pivotal Therapeutics Inc PVTTF

Healthcare Drug Manufacturers - Specialty & Generic
Pivotal Therapeutics Inc is a Canada based pharmaceutical company. It focuses on Omega-3 therapies for cardiovascular disease and overall health. The products of the company are VASCAZEN which is a prescription-only medical food for the treatment of an Omega-3 Deficiency in patients with cardiovascular disease, OMAZEN, and BENEFISHIAL which provides pure Omega-3 fatty acids for the maintenance... see more

Bullboard (GREY:PVTTF)

View:
Post by chance18on Aug 25, 2016 10:53pm

Are we toast.

You think the company would put something out .
431
Post by chance18on Jan 08, 2016 3:38pm

What's going on with this company.?

Do they have any customers or sales ?
512
Post by smithgeeon Jun 04, 2015 2:39pm

Pivotal enrolls first patient in Pomega phase IIa trial

Pivotal enrolls first patient in Pomega phase IIa trial     2015-06-04 14:31 ET - News Release     Dr. George Jackowski reports   FIRST PATIENT ENROLLED IN ...more  
491
Comment by Rosebud1964on May 07, 2014 11:59am

RE:Pivotal Therapeutics announces issuance of U.S. Patent 8,715

EOM? Have you been following PVO for awhile...thoughts?
532
Discussion
Post by picasso1on Mar 14, 2014 11:20pm

Ton of money

These guys raised a ton of money recently. That got me curious. It looks like there is no market right now for this stock. They should consider spending some marketing dollars.
840
Post by 1nvest0rson Oct 04, 2013 3:05pm

News on Pivotal Therapeutics

Pivotal Therapeutics to raise $5 mln through debt financing, $2.7 mln equity raise completed
369
Post by 1nvest0rson Aug 29, 2013 3:33pm

News on Pivotal Therapeutics

Pivotal Therapeutics says Q2 sales grow 27% as Vascazen impresses cardiologists
346
Post by Rosebud1964on Jun 18, 2013 3:44pm

Its alive!

Next stop $5
330
Post by Rosebud1964on May 31, 2013 11:03am

good read

https://www.proactiveinvestors.com/companies/news/44454/omthera-acquisition-highlights-upside-potential-of-pivotal-therapeutics-44454.html
399
Post by Rosebud1964on May 30, 2013 7:26pm

$$$

$5 with in the year!!
287
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities